Skip to main content
. 2015 Aug 19;10:174. doi: 10.1186/s13014-015-0471-z

Table 1.

Comparison of patient data

Item Standard dose group (n = 59) Experimental dose group (n = 58) p
Mean age (years)
56.1 58.1
SD 9.2 8.7 0.207
(t-Test)
Localization of spur
   Plantar 58 (98 %) 54 (93 %)
   Plantar and dorsal 1 (2 %) 4 (7 %) 0.350
Mean duration of pain (months) 16.5 16.7 0.882
   SD 21.2 23.2
Localization of pain
   Right = left 5 (7 %)
   Right > left 5 (8 %) 2 (3 %)
   Left > right 9 (16 %) 1 (2 %)
   Right only 26 (44 %) 22 (38 %)
   Left only 19 (32 %) 29 (50 %) 0.004
Extension of pain
   None 21 (36 %) 20 (34 %)
   Calf 15 (25 %) 17 (29 %)
   Sole of foot 16 (27 %) 15 (26 %)
   both 7 (12 %) 6 (11 %) 0.979
Start of pain
   Not known 2 (3 %) 1 (2 %)
   Suddenly 23 (39 %) 24 (41 %)
   Insidious 34 (58 %) 33 (57 %) >0.999
Impact of pain on life quality
   No impact 3 (5 %)
   Leisure 4 (7 %) 7 (12 %)
   Work 3 (5 %) 1 (2 %)
   Leisure and work 52 (88 %) 47 (81 %) 0.165
Effects on daily work
   Able to work 49 (83 %) 52 (90 %)
   Unable to work 7 (12 %) 2 (3 %)
   No occupancy 3 (5 %) 4 (7 %) 0.258
Effects on leisure/sports
   Unlimited 1 (2 %) 3 (5 %)
   Limited 40 (68 %) 37 (64 %)
   Impossible 16 (27 %) 17 (29 %)
   No sports 2 (3 %) 1 (3 %) 0.722
Former therapy using
   Ice/heat 7 (12 %) 3 (5 %) 0.322
   Ultrasound 8 (14 %) 15 (26 %) 0.108
   Microwaves 1 (2 %) 1 (2 %) >0.999
   Oral medication 36 (61 %) 39 (67 %) 0.564
   Injections 19 (32 %) 23 (40 %) 0.444
   Heel splints 56 (95 %) 55 (95 %) >0.999
   Other shoe adjustment 4 (7 %) 4 (7 %) >0.999
   Surgery 1 (2 %) 1 (2 %) >0.999
   (Multiple choices possible)

    SD standard deviation